[go: up one dir, main page]

CN112920066A - Alpha-substituted-alpha-amino acid ester compound and preparation method thereof - Google Patents

Alpha-substituted-alpha-amino acid ester compound and preparation method thereof Download PDF

Info

Publication number
CN112920066A
CN112920066A CN202110096999.4A CN202110096999A CN112920066A CN 112920066 A CN112920066 A CN 112920066A CN 202110096999 A CN202110096999 A CN 202110096999A CN 112920066 A CN112920066 A CN 112920066A
Authority
CN
China
Prior art keywords
amino acid
substituted
acid ester
butyl
ester compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110096999.4A
Other languages
Chinese (zh)
Inventor
杨少容
吴瑶丹
江焕峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China University of Technology SCUT
Original Assignee
South China University of Technology SCUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China University of Technology SCUT filed Critical South China University of Technology SCUT
Priority to CN202110096999.4A priority Critical patent/CN112920066A/en
Publication of CN112920066A publication Critical patent/CN112920066A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/02Formation of carboxyl groups in compounds containing amino groups, e.g. by oxidation of amino alcohols
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses an alpha-substituted-alpha-amino acid ester compound and a preparation method thereof. Adding aromatic amine and alkenyl ether into a reactor, dissolving in a solvent, reacting under the action of a palladium catalyst, a ligand and an oxidant, and separating and purifying to obtain the alpha-substituted-alpha-amino acid ester compound, wherein the reaction formula of the preparation method is shown as the formula (I). The method takes the alkenyl ether and the aromatic amine which are simple and easy to obtain as reaction raw materials to synthesize a series of alpha-substituted-alpha-amino acid ester compounds, and has the characteristics of simple and easy-to-obtain raw materials, convenient operation, mild conditions, high step atom economy, wide substrate applicability, good functional group tolerance and the like.
Figure DDA0002914338590000011

Description

Alpha-substituted-alpha-amino acid ester compound and preparation method thereof
Technical Field
The invention relates to the technical field of medicine and organic chemical synthesis, in particular to an alpha-substituted-alpha-amino acid ester compound and a preparation method thereof.
Background
The amino acid ester compound has amino and ester functional groups with relatively close space in the structure and a plurality of nitrogen and oxygen atoms with different chemical environments, so the amino acid ester compound is widely applied in the fields of medicine, agriculture, fine chemical engineering and the like. At present, the precise synthesis of multi-substituted and multi-functionalized complex amine compounds is always a very challenging subject.
Currently, there are relatively few methods for synthesizing α -substituted- α -amino acid esters, and three synthetic strategies are generally adopted, namely esterification of α -substituted- α -amino acids (org.lett.2019,21, 4873.; j.med.struc.2020,1209, 127974.; synthesis.2017,49,770.; org.biomol.chem.2020,18,6949.), a second commonly used strategy of nucleophilic substitution with amines at the α -position of the ester group (j.am.chem.soc.2004,126, 10846.; RSC adv.2013,3,17527.; New j.chem.2015,39,2657.), and a third of electrophilic substitution on the α -C of α -amino acid esters (angels.chem.ed.2012, 51,10808.). Although the above synthesis methods have made remarkable research progress in the construction of α -substituted- α -amino acid esters, the three synthesis methods have certain disadvantages, such as the need for pre-functionalization of raw materials (org. lett.2013,13, 3222.; j.am.chem.soc.2004,126,10846.), introduction of halogen atoms into the system (org. lett.2010,12,1936.;), harsh reaction conditions (angelw. chem.int.ed.2012,51,10808.), and the need for deprotection of amine groups (org. biomol.chem.2012,10,1565.), and thus it is very important to develop efficient and convenient synthesis methods for α -substituted- α -amino acid esters. Our group developed a new palladium-catalyzed electron-rich olefin tandem amination/oxidation process without a directing group to synthesize alpha-amino acid esters in 2017 (angelw. chem. int. ed.2017,56,15926.). However, the conditions of this reaction are not suitable for the internal olefin ether, and the synthesis of the α -substituted- α -amino acid ester cannot be carried out. Also, it can be seen from the existing synthesis techniques that the activity of internal olefins tends to be lower than that of terminal olefins, which is a ubiquitous limitation (Angew. chem. int. Ed.2010,49,1238.; org. Lett.2017,19,5717.; Angew. chem. int. Ed.2018,57,14911.).
On the other hand, a wide variety of ionic liquids can improve the homogeneous catalytic efficiency in metal-catalyzed reactions (Nature.2006,439, 831.; science.2003,302, 792.; chem. Commun.2006, 1049.). It is worth mentioning that the cations of ionic liquids are more accessible to charged centers (chem.commun.2018,54,2296.) and this process tends to promote many chemical reactions to proceed smoothly. In palladium-catalyzed reactions, ionic liquids can generally act as solvents or ligands, among others (Catal. Sci. technol.2021, DOI: 10.1039/D0CY01941K.; Catal. A.2020,599, 117599.; Org. Lett.2014,16,3008.; Org. Lett.2006,8,5199.). In the process, if the pure ionic environment of the ionic liquid is applied to the palladium-catalyzed coupling reaction, the mechanism and the route of the coupling reaction are possibly different from those of the traditional molecular solvent, so that a novel synthesis strategy is provided for the synthesis of complex multi-functionalized molecules. Therefore, the palladium-catalyzed olefin double-functionalization process is combined with the advantages of the ionic liquid, so that breakthrough of the traditional technical process can be realized on the synthesis method, and the original barriers of certain reactions are overcome. In conclusion, the development of a synthetic method with simple operation and simple and easily-obtained raw materials by using the alkenyl ether derivative as a substrate to construct the alpha-substituted-alpha-amino acid ester compound with diversified structures still remains a challenging research subject.
Disclosure of Invention
In order to overcome the defects and shortcomings of the prior art, the invention aims to provide an alpha-substituted-alpha-amino acid ester compound and a preparation method thereof. The method takes aromatic amine as a substrate, and alkenyl ether and the aromatic amine react to obtain the alpha-substituted-alpha-amino acid ester compound with diversified structures. The method has the advantages of easily available raw materials, simple operation and strong functional group tolerance, and provides an important technical support for the efficient synthesis of the alpha-substituted-alpha-amino acid ester derivatives with potential biological and pharmacological activities.
The purpose of the invention is realized by the following technical scheme:
an alpha-substituted-alpha-amino acid ester compound, the structural formula of which is:
Figure BDA0002914338570000021
wherein R is1Hydrogen, methyl, ethyl, pentyl, allyl, benzyl;
R2is benzene, o-methylbenzene, m-methylbenzene, p-methylbenzene, 4-fluorobenzene, 4-chlorobenzene, 4-bromobenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4-trifluoromethylbenzene, 2, 4-dichlorobenzene, mesitylene, naphthalene, benzyl and benzo seven-membered rings;
R3is methyl, ethyl, phenyl, 2, 4-difluorophenyl, 4-methoxyphenyl or benzyl;
R4methyl, ethyl, n-butyl, isobutyl, tert-butyl, cyclohexane, hydroxyethyl, 2-chloroethyl, phenyl, benzyl, allyl, thienylmethyl.
The preparation method of the alpha-substituted-alpha-amino acid ester compound comprises the following steps:
in a solvent, aromatic amine and alkenyl ether react under the action of a palladium catalyst, a ligand and an oxidant to obtain the alpha-substituted-alpha-amino acid ester compound.
The aromatic amine is
Figure BDA0002914338570000031
Alkenyl ether is
Figure BDA0002914338570000032
Wherein R is1Hydrogen, methyl, ethyl, pentyl, allyl, benzyl;
R2is benzene, o-methylbenzene, m-methylbenzene, p-methylbenzene, 4-fluorobenzene, 4-chlorobenzene, 4-bromobenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4-trifluoromethylbenzene, 2, 4-dichlorobenzene, mesitylene, naphthalene, benzyl and benzo seven-membered rings;
R3is methyl, ethyl, phenyl, 2, 4-difluorophenyl, 4-methoxyphenyl or benzyl;
R4is methyl, ethyl, n-butyl, isobutyl, tert-butyl, cyclohexane, hydroxyethyl, 2-chloroethyl, phenyl, benzyl, alkenePropyl, thienylmethyl.
Preferably, the aromatic amine is aniline, mesitylene, 3, 4-dichloroaniline, N-methylaniline, N-ethylaniline, N-pentylaniline, N-allylaniline, p-methoxy-N-methylaniline, p-trifluoromethyl-N-methylaniline, o-methyl-N-methyl, m-methyl-N-methylaniline, p-methyl-N-methylaniline, dibenzylamine, N-methylnaphthylamine;
preferably, the alkenyl ether is vinyl ethyl ether, vinyl n-butyl ether, vinyl cyclohexyl ether, vinyl phenyl ether, vinyl benzyl ether, vinyl-2-hydroxyethyl ether, vinyl allyl ether, propenyl ethyl ether, 1-butenylether, styrylether, 2-benzylvinyl ethyl ether.
Preferably, the catalyst is palladium chloride, bis (triphenylphosphine) palladium dichloride (i.e. bis (triphenylphosphine) palladium dichloride), palladium trifluoroacetate, bis (acetonitrile) palladium dichloride, bis (benzonitrile) palladium dichloride, bis (allyl) palladium dichloride (i.e. allyl palladium chloride dimer), or palladium acetate;
preferably, the ligand is 2, 2-bipyridine, 4-dimethoxy-2, 2-bipyridine, 4-dimethyl-2, 2-bipyridine, 6-dimethyl-2, 2-bipyridine, phenanthroline, 5-dimethyl-2, 2-bipyridine or 4, 5-diazafluoren-9-one.
Preferably, the oxidizing agent is one of benzoquinone, o-chloranil, naphthoquinone, iodobenzene acetate, manganese dioxide, sodium periodate and benzoyl peroxide.
Preferably, the solvent is an organic solvent or an ionic liquid, preferably an ionic liquid;
further preferably, the organic solvent is polyethylene glycol, N-dimethylformamide, dimethyl sulfoxide, toluene or 1, 4-dioxane; the ionic liquid is preferably imidazole type ionic liquid;
more preferably, the imidazole type ionic liquid is preferably a 1-butyl-3-methylimidazole type ionic liquid, and includes at least one of 1-butyl-3-methylimidazole chloride salt, 1-butyl-3-methylimidazole tetrafluoroborate, 1-butyl-3-methylimidazole hexafluorophosphate, 1-butyl-3-methylimidazole acetate and 1-butyl-3-methylimidazole bromide salt.
Preferably, the reaction conditions are as follows: the reaction temperature is 0-120 ℃; more preferably 20 to 35 ℃.
Preferably, the reaction time is 8-24 h.
Preferably, the reaction is carried out in an air atmosphere.
Preferably, the molar ratio of the aromatic amine to the alkenyl ether is 1 (2-4).
Preferably, the molar ratio of the catalyst to the aromatic amine is (0.05-0.2): 1.
Preferably, the molar ratio of the oxidant to the aromatic amine is (1-6): 1.
Preferably, the reaction is followed by subsequent treatment (separation and purification): and extracting, concentrating and purifying by column chromatography.
More preferably, the eluent of the column chromatography is a mixed solvent of petroleum ether and ethyl acetate, and the volume ratio of the petroleum ether to the ethyl acetate is (50-500): 1.
The reaction equation of the synthesis method of the invention is as follows:
Figure BDA0002914338570000041
the principle of the invention is that palladium is used as a catalyst in the air atmosphere, aromatic amine and alkenyl ether are used as raw materials, and a series of alpha-substituted-alpha-amino acid ester compounds are synthesized by a one-step method through amination oxidation reaction catalyzed by palladium. All the raw materials in the method are cheap and easy to obtain, the method is simple and easy to implement, and the operation is safe, so that the method has potential application value.
Compared with the prior art, the invention has the following advantages and effects:
the method successfully synthesizes the alpha-substituted-alpha-amino acid ester compound, and has the advantages of low price of raw materials, easy obtainment, safe and simple operation, strong functional group tolerance, wide substrate universality range, mild reaction conditions and high yield.
Drawings
FIG. 1 is a hydrogen spectrum of the product obtained in example 15;
FIG. 2 is a carbon spectrum of the product obtained in example 15;
FIG. 3 is a hydrogen spectrum of the product obtained in example 16;
FIG. 4 is a carbon spectrum of the product obtained in example 16;
FIG. 5 is a hydrogen spectrum of the product obtained in example 17;
FIG. 6 is a carbon spectrum diagram of the product obtained in example 17;
FIG. 7 is a hydrogen spectrum of the product obtained in example 18;
FIG. 8 is a carbon spectrum of the product obtained in example 18;
FIG. 9 is a hydrogen spectrum of the product obtained in example 19;
FIG. 10 is a carbon spectrum of the product obtained in example 19;
FIG. 11 is a hydrogen spectrum of the product obtained in example 20;
FIG. 12 is a carbon spectrum of the product obtained in example 20;
FIG. 13 is a hydrogen spectrum of the product obtained in example 21;
FIG. 14 is a carbon spectrum of the product obtained in example 21.
Detailed Description
The present invention is described in further detail below with reference to specific examples, but the embodiments and the scope of the present invention are not limited thereto. The high tolerance of the reaction functional group means that groups which are easy to convert such as halogen, chlorine and bromine can be reserved; the compound can also be applicable to heterocyclic rings containing nitrogen, sulfur and oxygen; for substituents containing alkenes, the alkenyl group can also remain unoxidized or converted.
Example 1
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium dichloride, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether and 1mL of [ Bmim ] were added under an air atmosphere]PF60.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying with 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum with a volume ratio of 100:1The yield of the mixed solvent of ether and ethyl acetate was 19%.
Example 2
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] were added under an air atmosphere]PF60.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 28%.
Example 3
In a 15mL test tube, 10% (10% of the molar amount of N-ethylaniline) of palladium acetate, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] were added under an air atmosphere]PF60.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 28%.
Example 4
In an air atmosphere, 5 percent (5 percent of molar amount of N-ethylaniline) palladium acetate, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ether, 1mL of DMF and 0.2mmol of hydrogen peroxide are added into a 15mL test tube, stirring is stopped after stirring reaction is carried out for 12 hours at room temperature, 5mL of water is added, extraction is carried out for 3 times by using ethyl acetate, organic phases are combined and dried by using 0.5g of anhydrous sodium sulfate, filtration and concentration under reduced pressure are carried out, and then separation and purification are carried out by thin layer chromatography, so as to obtain a target product, wherein a thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 9%.
Example 5
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 0.10mmol of N-ethylaniline and 0.20mmol of ethylene were added under an air atmosphereEthyl ether, 1mL [ Bmim ]]BF40.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 38%.
Example 6
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 46%.
Example 7
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 4, 4-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.2mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 44%.
Example 8
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.2mmol of bisAnd (2) adding oxygen water, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 75%.
Example 9
In an air atmosphere, 5 percent (5 percent of molar amount of N-ethylaniline) palladium acetate, 5 percent (5 percent of molar amount of N-ethylaniline) 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ether, 1mL of DMF and 0.2mmol of hydrogen peroxide are added into a 15mL test tube, stirring is stopped after stirring reaction is carried out for 12 hours at room temperature, 5mL of water is added, extraction is carried out for 3 times by using ethyl acetate, organic phases are combined and dried by using 0.5g of anhydrous sodium sulfate, filtration and concentration under reduced pressure are carried out, and then separation and purification are carried out by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 40%.
Example 10
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.1mmol of hydrogen peroxide and 0.1mmol of benzoquinone are stirred at room temperature for 12 hours, then the stirring is stopped, 5mL of water is added, extraction is carried out for 3 times by ethyl acetate, organic phases are combined and dried by 0.5g of anhydrous sodium sulfate, filtration and decompression concentration are carried out, and then separation and purification are carried out by thin layer chromatography, thus obtaining the target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 49%.
Example 11
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.3mmol of hydrogen peroxide, and stirring at room temperatureAfter 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with a volume ratio of 100: 1: ethyl acetate mixed solvent, yield 86%.
Example 12
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.3mmol of hydrogen peroxide, stirring and reacting for 12 hours at 50 ℃, stopping stirring, adding 5mL of water, extracting for 3 times by using ethyl acetate, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 67%.
Example 13
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.3mmol of hydrogen peroxide, stirring and reacting for 12 hours at 120 ℃, stopping stirring, adding 5mL of water, extracting for 3 times by using ethyl acetate, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 31%.
Example 14
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.3mmol of hydrogen peroxide, stirring at room temperature for 24 hours, and stopping stirringAdding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with a volume ratio of 100: 1: ethyl acetate mixed solvent, yield 87%.
Example 15
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethoxy-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.30mmol of vinyl ethyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.3mmol of hydrogen peroxide, stirring and reacting for 12 hours at room temperature, stopping stirring, adding 5mL of water, extracting for 3 times by ethyl acetate, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 100: 1: ethyl acetate mixed solvent, yield 91%.
The structural characterization data of the product obtained in example 15 are as follows (nuclear magnetic spectrum as shown in fig. 1 (hydrogen-spectrum) and fig. 2 (carbon-spectrum)):
1H NMR(400MHz,CDCl3)δ7.20(t,J=7.6Hz,2H),6.70(t,J=7.2Hz,1H),6.64(d,J=7.6Hz,2H),4.18(q,J=7.2Hz,2H),4.00(s,2H),3.46(q,J=7.2Hz,2H),1.25(t,J=7.0Hz,3H),1.20(t,J=7.0Hz,3H).
13C NMR(100MHz,CDCl3)δ171.3,147.8,129.2,116.8,112.0,60.8,52.3,46.0,14.2,12.4ppm.
IR(KBr):3554,3304,3073,2976,1747,1605,1508,1192,1027,751cm-1.
HRMS-ESI(m/z):calculated for[C11H15NO2+Na]+:216.0995,found 216.0996.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000091
example 16
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of 4-bromo-N-methylaniline, 0.20mmol of vinyl ether, and 1mL of [ Bmim ]]BF40.4mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 200: 1: ethyl acetate mixed solvent, yield 50%.
The structural characterization data of the product obtained in example 16 are as follows (nuclear magnetic spectrum as shown in fig. 3 (hydrogen-spectrum) and fig. 4 (carbon-spectrum)):
1H NMR(400MHz,CDCl3)δ7.29(d,J=8.0Hz,2H),6.54(d,J=8.4Hz,2H),4.17(q,J=7.2Hz,2H),4.02(s,2H),3.03(s,3H),1.24(t,J=7.4Hz,3H).
13C NMR(100MHz,CDCl3)δ170.5,147.9,131.8,113.9,109.3,61.0,54.4,39.6,14.2ppm.
IR(KBr):3366,2950,1738,1493,1199,805cm-1.
HRMS-ESI(m/z):calculated for[C11H14NO2Br+Na]+:294.0100,found 294.0104.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000101
example 17
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of dibenzylamine, 0.20mmol of vinyl ethyl ether, and 1mL of [ Bmim ]]BF40.4mmol of hydrogen peroxide, stirring and reacting for 12 hours at room temperature, and stopping reactionStirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with a volume ratio of 500: 1: ethyl acetate mixed solvent, yield 72%.
The structural characterization data of the product obtained in example 17 are as follows (nuclear magnetic spectrum as shown in fig. 5 (hydrogen-spectrum) and fig. 6 (carbon-spectrum)):
1H NMR(500MHz,CDCl3)δ7.38(d,J=8.0Hz,4H),7.30(t,J=7.5Hz,4H),7.22(t,J=7.3Hz,2H),4.13(q,J=7.2Hz,2H),3.80(s,4H),3.27(s,2H),1.24(t,J=7.3Hz,3H).
13C NMR(125MHz,CDCl3)δ171.3,139.0,128.8,128.2,127.0,60.1,57.7,53.5,14.2ppm.
IR(KBr):2843,1724,1466,1190,723cm-1.
HRMS-ESI(m/z):calculated for[C18H21NO2+H]+:284.1645,found 284.1650.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000111
example 18
In a 15mL test tube, 10% (10% of the molar amount of N-ethylaniline) of palladium acetate, 10% (10% of the molar amount of N-ethylaniline) of 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinylphenyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.4mmol of hydrogen peroxide, stirring at room temperature for 16 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 50: 1: ethyl acetate mixed solvent, yield 52%.
The structural characterization data of the product obtained in example 18 are as follows (nuclear magnetic spectrum as shown in fig. 7 (hydrogen-spectrum) and fig. 8 (carbon-spectrum)):
1H NMR(400MHz,CDCl3)δ7.34(t,J=7.6Hz,2H),7.25(t,J=7.9Hz,3H),7.06(d,J=8.0Hz,2H),6.83-6.68(m,3H),4.26(s,2H),3.55(q,J=7.1Hz,2H),1.26(t,J=5.3Hz,3H).
13C NMR(100MHz,CDCl3)δ170.1,150.5,147.6,129.4,129.4,125.9,121.3,117.2,112.2,52.6,46.2,29.7,12.6ppm.
IR(KBr):3371,2975,1751,1487,1146,738cm-1.
HRMS-ESI(m/z):calculated for[C16H17NO2+Na]+:278.1151,found 278.1150.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000121
example 19
In a 15mL test tube, 5% (5% of the molar amount of N-ethylaniline) of palladium acetate, 5% (5% of the molar amount of N-ethylaniline) of 5, 5-dimethyl-2, 2-bipyridine, 0.10mmol of N-ethylaniline, 0.20mmol of vinyl allyl ether, and 1mL of [ Bmim ] in an air atmosphere]BF40.4mmol of hydrogen peroxide, stirring and reacting for 12 hours at room temperature, stopping stirring, adding 5mL of water, extracting for 3 times by using ethyl acetate, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 500: 1: ethyl acetate mixed solvent, yield 56%.
The structural characterization data of the product obtained in example 19 are as follows (nuclear magnetic spectrum as shown in fig. 9 (hydrogen-spectrum) and fig. 10 (carbon-spectrum)):
1H NMR(400MHz,CDCl3)δ7.21(t,J=7.4Hz,2H),6.71(t,J=7.3Hz,1H),6.65(d,J=7.9Hz,2H),5.90(ddt,J=16.7,11.2,5.7Hz,1H),5.26(dd,J=26.1,13.8Hz,2H),4.63(d,J=5.6Hz,2H),4.05(s,2H),3.47(q,J=7.0Hz,2H),1.21(t,J=7.1Hz,3H).
13C NMR(100MHz,CDCl3)δ171.0,147.7,131.8,129.2,118.5,116.9,112.1,65.5,52.2,46.0,12.4ppm.
IR(KBr):2948,1743,1600,1501,1368,1179,981,747cm-1.
HRMS-ESI(m/z):calculated for[C13H17NO2+Na]+:242.1151,found 242.1156.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000122
example 20
In a 15mL test tube, 10% (10% of the molar amount of N-ethylaniline) of palladium acetate, 10% (10% of the molar amount of N-ethylaniline) of 4, 5-diazafluoren-9-one, 0.10mmol of N-ethylaniline, 0.20mmol of propylene ethyl ether, and 1mL of [ Bmim ]]BF40.6mmol of hydrogen peroxide, stirring at room temperature for 12 hours, stopping stirring, adding 5mL of water, extracting with ethyl acetate for 3 times, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 200: 1: ethyl acetate mixed solvent, yield 86%.
The structural characterization data of the product obtained in example 20 are as follows (nuclear magnetic spectrum as shown in fig. 11 (hydrogen-spectrum) and fig. 12 (carbon-spectrum)):
1H NMR(500MHz,CDCl3)δ7.28(t,J=7.9Hz,2H),6.80(dd,J=8.0Hz,3H),4.48(q,J=7.2Hz,1H),4.22(dd,J=3.8,2H),3.47(q,J=7.2Hz,2H),1.57(d,J=7.2Hz,3H),1.29(t,J=6.1Hz,3H),1.27(t,J=5.7Hz,3H).
13C NMR(125MHz,CDCl3)δ173.7,148.1,129.1,117.2,113.6,60.7,57.1 41.5,15.9,14.4,14.1ppm.
IR(KBr):2973,1732,1598,1500,1190,750cm-1.
HRMS-ESI(m/z):calculated for[C13H19NO2+H]+:222.1489,found 222.1493.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000131
example 21
In a 15mL test tube, 10% (10% of the molar amount of N-ethylaniline) of palladium acetate, 10% (10% of the molar amount of N-ethylaniline) of 4, 5-diazafluoren-9-one, 0.10mmol of N-ethylaniline, 0.20mmol of styrene ethyl ether, and 1mL of [ Bmim ]]BF40.6mmol of hydrogen peroxide, stirring and reacting for 20 hours at room temperature, stopping stirring, adding 5mL of water, extracting for 3 times by ethyl acetate, combining organic phases, drying by using 0.5g of anhydrous sodium sulfate, filtering, concentrating under reduced pressure, and separating and purifying by thin layer chromatography to obtain a target product, wherein the thin layer chromatography developing agent is petroleum ether with the volume ratio of 400: 1: ethyl acetate mixed solvent, yield 51%.
The structural characterization data of the product obtained in example 21 are as follows (nuclear magnetic spectrum as shown in fig. 13 (hydrogen-spectrum) and fig. 14 (carbon-spectrum)):
1H NMR(400MHz,CDCl3)δ7.35(d,J=4.9Hz,5H),7.25(t,J=8.0Hz,2H),6.86(d,J=8.2Hz,2H),6.79(t,J=7.3Hz,1H),5.52(s,1H),4.24-4.20(m,1H),3.33(d,J=7.0Hz,2H),1.23(t,J=7.1Hz,3H),0.91(t,J=7.0Hz,3H).
13C NMR(100MHz,CDCl3)δ172.0,148.5,136.1,129.2,128.9,128.5,128.1,118.2,114.5,66.3,61.1,42.5,14.2,13.4ppm.
IR(KBr):2955,1735,1592,1493,1173,748cm-1.
HRMS-ESI(m/z):calculated for[C18H21NO2+H]+:284.1640,found 284.1645.
the structure of the resulting product was deduced from the above data as follows:
Figure BDA0002914338570000141
the above examples of the present invention are merely examples for clearly illustrating the present invention and are not intended to limit the embodiments of the present invention. Other variations and modifications will be apparent to persons skilled in the art in light of the above description. And are neither required nor exhaustive of all embodiments. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention should be included in the protection scope of the claims of the present invention.

Claims (10)

1.一种α-取代-α-氨基酸酯类化合物,其特征在于,其结构式为:1. an α-substituted-α-amino acid ester compound is characterized in that, its structural formula is:
Figure FDA0002914338560000011
Figure FDA0002914338560000011
其中,R1为氢、甲基、乙基、戊基、烯丙基、苄基;Wherein, R 1 is hydrogen, methyl, ethyl, pentyl, allyl, benzyl; R2为苯、邻甲基苯、间甲基苯、对甲基苯、4-氟苯、4-氯苯、4-溴苯、4-叔丁基苯、4-甲氧基苯、4-三氟甲基苯、2,4-二氯苯、均三甲苯、萘、苄基、苯并七元环;R 2 is benzene, o-methylbenzene, m-methylbenzene, p-methylbenzene, 4-fluorobenzene, 4-chlorobenzene, 4-bromobenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4- -Trifluoromethylbenzene, 2,4-dichlorobenzene, mesitylene, naphthalene, benzyl, benzos seven-membered ring; R3为甲基、乙基、苯基、2,4-二氟苯基、4-甲氧基苯基、苄基;R 3 is methyl, ethyl, phenyl, 2,4-difluorophenyl, 4-methoxyphenyl, benzyl; R4为甲基、乙基、正丁基、异丁基、叔丁基、环己烷、羟乙基、2-氯乙基、苯基、苄基、烯丙基、噻吩甲基。R 4 is methyl, ethyl, n-butyl, isobutyl, tert-butyl, cyclohexane, hydroxyethyl, 2-chloroethyl, phenyl, benzyl, allyl, thienylmethyl.
2.权利要求1所述的α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,包括以下步骤:2. the preparation method of the α-substituted-α-amino acid ester compound described in claim 1, is characterized in that, comprises the following steps: 在溶剂中,将芳香胺、烯基醚在钯催化剂、配体和氧化剂的作用下进行反应,获得α-取代-α-氨基酸酯类化合物;In a solvent, the aromatic amine and alkenyl ether are reacted under the action of palladium catalyst, ligand and oxidant to obtain α-substituted-α-amino acid ester compound; 所述芳香胺为
Figure FDA0002914338560000012
烯基醚为
Figure FDA0002914338560000013
The aromatic amine is
Figure FDA0002914338560000012
Alkenyl ethers are
Figure FDA0002914338560000013
其中,R1为氢、甲基、乙基、戊基、烯丙基、苄基;Wherein, R 1 is hydrogen, methyl, ethyl, pentyl, allyl, benzyl; R2为苯、邻甲基苯、间甲基苯、对甲基苯、4-氟苯、4-氯苯、4-溴苯、4-叔丁基苯、4-甲氧基苯、4-三氟甲基苯、2,4-二氯苯、均三甲苯、萘、苄基、苯并七元环;R 2 is benzene, o-methylbenzene, m-methylbenzene, p-methylbenzene, 4-fluorobenzene, 4-chlorobenzene, 4-bromobenzene, 4-tert-butylbenzene, 4-methoxybenzene, 4- -Trifluoromethylbenzene, 2,4-dichlorobenzene, mesitylene, naphthalene, benzyl, benzos seven-membered ring; R3为甲基、乙基、苯基、2,4-二氟苯基、4-甲氧基苯基、苄基;R 3 is methyl, ethyl, phenyl, 2,4-difluorophenyl, 4-methoxyphenyl, benzyl; R4为甲基、乙基、正丁基、异丁基、叔丁基、环己烷、羟乙基、2-氯乙基、苯基、苄基、烯丙基、噻吩甲基。R 4 is methyl, ethyl, n-butyl, isobutyl, tert-butyl, cyclohexane, hydroxyethyl, 2-chloroethyl, phenyl, benzyl, allyl, thienylmethyl.
3.根据权利要求2所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,3. the preparation method of α-substituted-α-amino acid ester compound according to claim 2, is characterized in that, 所述钯催化剂为氯化钯、二氯二(三苯基膦)钯、三氟乙酸钯、二氯二(乙腈)钯、二氯二(苯腈)钯、二(烯丙基)二氯化钯或醋酸钯;The palladium catalyst is palladium chloride, dichlorobis(triphenylphosphine) palladium, trifluoroacetate palladium, dichlorobis(acetonitrile) palladium, dichlorobis(benzonitrile) palladium, bis(allyl) dichloride Palladium or palladium acetate; 所述配体为2,2-联吡啶、4,4-二甲氧基-2,2-联吡啶、4,4-二甲基-2,2-联吡啶、6,6-二甲基-2,2-联吡啶、菲罗啉、5,5-二甲基-2,2-联吡啶或4,5-二氮芴-9-酮;The ligands are 2,2-bipyridine, 4,4-dimethoxy-2,2-bipyridine, 4,4-dimethyl-2,2-bipyridine, 6,6-dimethylpyridine -2,2-bipyridine, phenanthroline, 5,5-dimethyl-2,2-bipyridine or 4,5-diazafluoren-9-one; 所述氧化剂为苯醌、邻四氯苯醌、萘醌、醋酸碘苯、二氧化锰、高碘酸钠、过氧化苯甲酰中的一种。The oxidant is one of benzoquinone, o-tetrachlorobenzoquinone, naphthoquinone, iodobenzene acetate, manganese dioxide, sodium periodate, and benzoyl peroxide. 4.根据权利要求2所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,所述溶剂为有机溶剂或离子液体。4. The preparation method of the α-substituted-α-amino acid ester compound according to claim 2, wherein the solvent is an organic solvent or an ionic liquid. 5.根据权利要求4所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,所述的有机溶剂为聚乙二醇、N,N-二甲基甲酰胺、二甲基亚砜、甲苯或1,4-二氧六环;所述离子液体为咪唑型离子液体。5. the preparation method of α-substituted-α-amino acid ester compound according to claim 4, is characterized in that, described organic solvent is polyethylene glycol, N,N-dimethylformamide, dimethylformamide Sulfoxide, toluene or 1,4-dioxane; the ionic liquid is an imidazole type ionic liquid. 6.根据权利要求5所述合成α-取代-α-氨基酸酯类化合物的方法,其特征在于,所述咪唑型离子液体为1-丁基-3-甲基咪唑型离子液体。6 . The method for synthesizing α-substituted-α-amino acid ester compounds according to claim 5 , wherein the imidazole-type ionic liquid is a 1-butyl-3-methylimidazole-type ionic liquid. 7 . 7.根据权利要求6所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,所述1-丁基-3-甲基咪唑型离子液体为1-丁基基-3-甲基咪唑氯盐、1-丁基-3-甲基咪唑四氟硼酸盐、1-丁基-3-甲基咪唑六氟磷酸盐、1-丁基-3-甲基咪唑醋酸盐、1-丁基-3-甲基咪唑溴盐中一种或多种。7. the preparation method of α-substituted-α-amino acid ester compound according to claim 6, is characterized in that, described 1-butyl-3-methylimidazole type ionic liquid is 1-butyl-3- Methylimidazolium chloride, 1-butyl-3-methylimidazolium tetrafluoroborate, 1-butyl-3-methylimidazolium hexafluorophosphate, 1-butyl-3-methylimidazolium acetate , one or more of 1-butyl-3-methylimidazolium bromide. 8.根据权利要求2所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,8. the preparation method of α-substituted-α-amino acid ester compound according to claim 2, is characterized in that, 所述反应在空气氛围中进行;The reaction is carried out in an air atmosphere; 所述反应的温度为0~120℃,反应的时间为8~24h;The temperature of the reaction is 0~120℃, and the time of the reaction is 8~24h; 所述芳香胺和烯基醚的摩尔比为1:(2~4);The molar ratio of the aromatic amine and the alkenyl ether is 1:(2~4); 所述钯催化剂与芳香胺的摩尔比为(0.05~0.2):1;The molar ratio of the palladium catalyst to the aromatic amine is (0.05~0.2):1; 所述氧化剂与芳香胺的摩尔比为(1~6):1。The molar ratio of the oxidant to the aromatic amine is (1-6):1. 9.根据权利要求8所述合成α-取代-α-氨基酸酯类化合物的方法,其特征在于,所述反应的温度为20~35℃。9 . The method for synthesizing α-substituted-α-amino acid ester compounds according to claim 8 , wherein the reaction temperature is 20-35° C. 10 . 10.根据权利要求2所述α-取代-α-氨基酸酯类化合物的制备方法,其特征在于,所述反应完成后进行后续处理:将反应完后的产物进行萃取,浓缩,柱层析提纯。10. according to the preparation method of the described α-substituted-α-amino acid ester compound of claim 2, it is characterized in that, after described reaction is completed, carry out follow-up treatment: the product after reaction is extracted, concentrated, column chromatography purifies .
CN202110096999.4A 2021-01-25 2021-01-25 Alpha-substituted-alpha-amino acid ester compound and preparation method thereof Pending CN112920066A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110096999.4A CN112920066A (en) 2021-01-25 2021-01-25 Alpha-substituted-alpha-amino acid ester compound and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110096999.4A CN112920066A (en) 2021-01-25 2021-01-25 Alpha-substituted-alpha-amino acid ester compound and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112920066A true CN112920066A (en) 2021-06-08

Family

ID=76167055

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110096999.4A Pending CN112920066A (en) 2021-01-25 2021-01-25 Alpha-substituted-alpha-amino acid ester compound and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112920066A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113773221A (en) * 2021-10-08 2021-12-10 湖北工业大学 P-benzoquinone compound and preparation method thereof
CN115322100A (en) * 2022-08-30 2022-11-11 南京工业大学 Delta, epsilon-alkenyl ketone compound and preparation method and application thereof
CN115894299A (en) * 2022-12-06 2023-04-04 华南理工大学 A kind of preparation method of axial chiral carbamate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101270076A (en) * 2008-05-13 2008-09-24 复旦大学 A kind of preparation method of natural product (3S, 9S)-Ciliatamides C
CN103113247A (en) * 2013-03-13 2013-05-22 苏州大学 Method for preparing amino-acid ester
CN103896782A (en) * 2012-12-26 2014-07-02 北京奥得赛化学股份有限公司 Method of preparing 2-(N, N- dimethylamino)-2 phenyl butanol
CN107011195A (en) * 2017-03-31 2017-08-04 华南理工大学 A kind of method by catalysis oxidation one-step synthesis alpha amino acid ester type compound

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101270076A (en) * 2008-05-13 2008-09-24 复旦大学 A kind of preparation method of natural product (3S, 9S)-Ciliatamides C
CN103896782A (en) * 2012-12-26 2014-07-02 北京奥得赛化学股份有限公司 Method of preparing 2-(N, N- dimethylamino)-2 phenyl butanol
CN103113247A (en) * 2013-03-13 2013-05-22 苏州大学 Method for preparing amino-acid ester
CN107011195A (en) * 2017-03-31 2017-08-04 华南理工大学 A kind of method by catalysis oxidation one-step synthesis alpha amino acid ester type compound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113773221A (en) * 2021-10-08 2021-12-10 湖北工业大学 P-benzoquinone compound and preparation method thereof
CN113773221B (en) * 2021-10-08 2023-09-29 湖北工业大学 A kind of p-benzoquinone compound and preparation method thereof
CN115322100A (en) * 2022-08-30 2022-11-11 南京工业大学 Delta, epsilon-alkenyl ketone compound and preparation method and application thereof
CN115894299A (en) * 2022-12-06 2023-04-04 华南理工大学 A kind of preparation method of axial chiral carbamate
CN115894299B (en) * 2022-12-06 2024-03-12 华南理工大学 A kind of preparation method of axial chiral carbamate

Similar Documents

Publication Publication Date Title
CN112920066A (en) Alpha-substituted-alpha-amino acid ester compound and preparation method thereof
CN108409747B (en) Synthetic method of 2-aminoquinoline dihydrofuran compound
CN109776381B (en) A kind of preparation method of spirocyclic indolinone compounds in water phase
CN110028403B (en) A kind of method of synthesizing succinic acid compounds
CN110099893B (en) Preparation method of droxidopa and intermediate thereof
CN107141248A (en) A kind of method that visible light catalytic synthesizes the ketene compound of 3 sulfuryl loop coil three
Kadoh et al. Enhanced structural variety of nonplanar N-oxyl radical catalysts and their application to the aerobic oxidation of benzylic C–H bonds
CN111718372B (en) Axial chiral phosphine-ene ligand and preparation method and application thereof
CN116768771A (en) Method for preparing thioimine compounds by catalytic selective oxidation
CN113200933B (en) Method for synthesizing optically active benzocarboxylate compound by asymmetric addition reaction
CN106883206B (en) Method for synthesizing coumarin by catalyzing (E) -o-hydroxycinnamaldehyde derivative with aza-carbene
CN112645836B (en) A kind of heterogeneous catalyst Cu@COF-Me-M and its preparation method and application
CN113549062A (en) A large sterically hindered chiral quaternary ammonium salt phase transfer catalyst derived from cinchonadine and its synthesis method
CN113620918A (en) A method for the synthesis of spiro compounds by Lewis acid-catalyzed [3+2] cycloaddition
CN109867614B (en) 4, 4-dialkyl sulfide-1-phenyl-3-butylene-1-ketone derivative and synthetic method thereof
CN112694430B (en) A kind of preparation method of 1,5-dihydro-2H-pyrrole-2-one compound
CN111747875A (en) Cyanoalkoxy-substituted tetra-substituted alkene derivatives and their synthesis
CN116199614A (en) A kind of N-N axis chiral indole-pyrrole compound and its synthesis method
CN108440384A (en) The preparation method of the trifluoromethyl hydroxylation derivative of isoindolone
CN115626892A (en) Oxidation/cyclization reaction method of en-yne amine compounds under a kind of non-noble metal condition
CN110294708B (en) Preparation method of trifluoroethelenylphenanthridine and 3,4-dihydroisoquinoline derivatives
CN107417583B (en) Method for selectively synthesizing allyl sulfone compounds using non-metallic catalysts
CN115385831B (en) A method for preparing alkyne sulfone compounds by oxidation using a selenium-containing catalytic system
CN111285846B (en) A kind of 2-(2-indolyl)-acetate derivative and its synthetic method
CN114989065B (en) Preparation method of indole dimer compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210608